Work

Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial

Year: 2020

Type: article

Abstract: Use of growth hormone is associated with side effects, including insulin resistance. The objective of this study was to determine whether tesamorelin, a stabilized growth hormone-releasing hormone analogue, would alter insulin sensitivity or control of diabetes.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/m5t5-ts91

Authors: Clemmons, David R., Mamputu, Jean-Claude, Miller, Sam

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4300877756

FWCI:

Cites:

Cited by:

Related to: 10